Guideline of neuropathic pain treatment and dilemma from neurological point of view

Acta Neurologica Taiwanica

Volumn 21, Issue 3, 2012, Pages 136-144

  Yang, Chun Ming ^a   Chen, Nan Cheng ^a   Shen, Hsiu Chu ^a   Chou, Chi Ho ^a   Yeh, Poh Shiow ^a,b   Lin, Huey Juan ^a,b   Chang, Chia Yu ^a   Cheng, Tain Junn ^a,b   Lin, Kao Chang ^a  

^a SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Guidelines; Mechanism based; Neuropathic pain; Non pharmacological; Pharmacological

Indexed keywords

4 AMINOBUTYRIC ACID; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; MORPHINE; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUPUNCTURE; ANALGESIA; CANCER PAIN; COMPLEX REGIONAL PAIN SYNDROME; DIABETIC NEUROPATHY; EVIDENCE BASED MEDICINE; HUMAN; NEUROPATHIC PAIN; POLYPHARMACY; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; REVIEW; SENSITIZATION; TAIWAN; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

ANALGESICS; GUIDELINES AS TOPIC; HUMANS; NEURALGIA;

EID: 84871045907     PISSN: 1028768X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Craig KD, & Hadjistavropoulos, T. Psychological perspectives on pain: Controversies. In Hadjistavropoulos, T., & Craig, K. D. (Eds.) Pain: Psychological perspectives. New York: Erlbaum 2004; p303-p26.
2. Bonica JJ. The need of a taxonomy. Pain 1979; 6: 247-252.
3. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-1635. (Pubitemid 351620320)
4. Bennett GJ. Neuropathic pain: an overview. In: Borsook D, ed. Molecular neurobiology of pain. Seattle, WA: IASP Press 1997: 109-113.
5. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008; 137: 681-688.
6. Smith BH, Torrance N. Epidemiology of neuropathic pain. Pain Management 2011; 1: 87-96.
7. Baron R. Mechanism of Disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2006; 2: 95-106. (Pubitemid 43210250)
8. Finnerup N, Troels JS. Mechanisms of Disease: mecha-nism- based classification of neuropathic pain-a critical analysis. Nature Clinical Practice 2006; 2: 107-115. (Pubitemid 43210251)
9. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanism and treatment. Lancet Neurology 2010; 9: 807-819.
10. Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic Pain: a practical guide for the clinician. CMAJ 2006; 265-275. (Pubitemid 44230827)
11. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009; 32: 1-32.
12. Taiwan Guidance for Total Pain Management. 2010; 111-83 .
13. Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009; 339: b3002.
14. Melzack R. Gate control theory: On the evolution of pain concepts. Pain Forum 1996; 5: 128-138.
15. Tan T, Barry P, Reken S, Baker M; Guideline Development Group. Pharmacological management of neuropathic pain in adults in non-specialist settings: summary of NICE guidance. BMJ 2010; 340: c1079.
16. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007; 132: 237-251. (Pubitemid 350051570)
17. Cruccu G, Sommer C, Anand P, Attal N, Baron R, Garcia- Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17: 1010-1018.
18. Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152: 14-27.
19. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758-1765.
20. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM; American Academy of Neurology Society; European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-1028.
21. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP, Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY; Taiwan SJS Consortium. Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan. N Engl J Med 2011; 364: 1126-1133.